Nick Zheng
Long/short equity, event-driven, biotech
Nick Zheng
Contributor since: 2013
Mark Chapman, Contributor
Amit Ghate, Contributor
EP Vantage, Contributor
Wunderkind Research, Contributor
George Rho, Contributor
Nick Zheng, Contributor
Biotech Sage, Contributor